Wms Partners, LLC Pfizer Inc Transaction History

Wms Partners, LLC

$1.7 Billion
Q3 2024

A detailed history of Wms Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wms Partners, LLC holds 50,608 shares of PFE stock, worth $1.34 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

50,608

Previous 47,159 7.31%

Holding current value

$1.34 Million

Previous $1.32 Million 10.99%

% of portfolio

0.09%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $95,537 - $108,264	3,449 Added 7.31%	50,608 $1.46 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $27,457 - $32,175	-1,087 Reduced 2.25%	47,159 $1.32 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $10,925 - $12,546	422 Added 0.88%	48,246 $1.34 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $140,945 - $183,072	-5,394 Reduced 10.14%	47,824 $1.38 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $27,501 - $32,146	-857 Reduced 1.58%	53,218 $1.77 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $16,579 - $19,181	-459 Reduced 0.84%	54,075 $1.98 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $44,392 - $57,792	1,127 Added 2.11%	54,534 $2.22 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $361,262 - $471,588	-8,653 Reduced 13.94%	53,407 $2.74 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $63,320 - $77,298	-1,447 Reduced 2.28%	62,060 $2.72 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $44,110 - $52,301	948 Added 1.52%	63,507 $3.33 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $216,855 - $268,710	4,740 Added 8.2%	62,559 $3.24 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $30,411 - $45,080	-736 Reduced 1.26%	57,819 $3.41 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $353 - $453	9 Added 0.02%	58,555 $2.52 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $43,738 - $49,548	-1,218 Reduced 2.04%	58,546 $2.29 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $56,698 - $63,944	1,693 Added 2.92%	59,764 $2.17 Million
Q4 2020 Feb 17, 2021	SELL	$33.47 - $42.56 $111,120 - $141,299	-3,320 Reduced 5.41%	58,071 $2.14 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $2,032 - $2,384	64 Added 0.1%	61,391 $2.25 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $9,879 - $11,985	-328 Reduced 0.53%	61,327 $2.01 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $117,688 - $168,151	-4,354 Reduced 6.6%	61,655 $2.01 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $211,543 - $240,075	-6,426 Reduced 8.87%	66,009 $2.59 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $6,790 - $8,805	-209 Reduced 0.29%	72,435 $2.6 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $256,123 - $287,567	6,926 Added 10.54%	72,644 $3.15 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $4,837 - $5,314	-129 Reduced 0.2%	65,718 $2.79 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $366,465 - $417,810	9,526 Added 16.91%	65,847 $2.87 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $52,532 - $63,718	-1,524 Reduced 2.63%	56,321 $2.48 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $67,246 - $71,691	-2,039 Reduced 3.4%	57,845 $2.1 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $11,328 - $13,142	-355 Reduced 0.59%	59,884 $2.13 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $31,530 - $33,454	948 Added 1.6%	60,239 $2.18 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $13,330 - $14,684	430 Added 0.73%	59,291 $2.12 Million
Q2 2017 Aug 09, 2017	BUY	N/A	58,861	58,861 $1.98 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Account